Ying Gao

Ying Gao

Auto-generated profile, based on publicly available information

Ying Gao

Department of Chemistry and The Swire Institute of Marine Science, The University of Hong Kong, Hong Kong, China

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
8 June 2024 in Nature Communications
Verified
Journal Article
Open access
PDF file
ZCZhuo Cheng
Zhuo Cheng
BHBei-Bei He
Bei-Bei He
KLKangfan Lei
Kangfan Lei
YGYing Gao
Ying Gao
YSYuqi Shi
Yuqi Shi
YLYongxin Li
Yongxin Li
Antimicrobial resistance remains a significant global threat, driving up mortality rates worldwide. Ribosomally synthesized and post-translationally modified peptides have emerged as a promising source of novel peptide antibiotics due to their diverse chemical structures. Here, we report the discovery of new aminovinyl-(methyl)cysteine (Avi(Me)Cys)-containing peptide antibiotics through a synergistic approach combining biosynthetic rule-based omics mining and heterologous expression. We first bioinformatically identify 1172 RiPP biosynthetic gene clusters (BGCs) responsible for Avi(Me)Cys-containing peptides formation from a vast pool of over 50,000 bacterial genomes. Subsequently, we successfully establish the connection between three identified BGCs and the biosynthesis of five peptide antibiotics via biosynthetic rule-guided metabolic analysis. Notably, we discover a class V lanthipeptide, massatide A, which displays excellent activity against gram-positive pathogens, including drug-resistant clinical isolates like linezolid-resistantS. aureusand methicillin-resistantS. aureus, with a minimum inhibitory concentration of 0.25 μg/mL. The remarkable performance of massatide A in an animal infection model, coupled with a relatively low risk of resistance and favorable safety profile, positions it as a promising candidate for antibiotic development. Our study highlights the potential of Avi(Me)Cys-containing peptides in expanding the arsenal of antibiotics against multi-drug-resistant bacteria, offering promising drug leads in the ongoing battle against infectious diseases.

7 February 2024 in Nature Chemistry
Verified
Journal Article
Closed access
PDF file
YZYu Zhou
Yu Zhou
WSWenyin Shen
Wenyin Shen
YGYing Gao
Ying Gao
JPJianzhao Peng
Jianzhao Peng
QLQingrong Li
Qingrong Li
XLXiaoyu Li
Xiaoyu Li